Products
Our current treatments.
CAVHANZA™ (nilotinib) Orally Disintegrating Tablets
Approved in the US.
BAFIERTAM® (monomethyl fumarate) Delayed-Release Capsules
Approved in the US.
VENXXIVA™ (tiopronin) Delayed-Release Tablets
Approved in the US.
ORMALVI (dichlorphenamide) Tablets
Approved in the US.
JAVYGTOR™ (sapropterin dihydrochloride)
Approved in the US.
For NITYR® distribution information in the US market please contact +1-800-847-8714.
Patient Support Programme
Life-changing treatments need life-improving product support to match. That’s why we created Cycle Vita™, our patient support programme for patients in the US. It delivers individualised emotional, financial,* and product support that patients need at every step of their journey.
State Regulations Information
Information for US Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131
*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at +1 (888) 360- 8482.